Cargando…

Next-generation proteasome inhibitor oprozomib synergizes with modulators of the unfolded protein response to suppress hepatocellular carcinoma

Hepatocellular carcinoma (HCC) responds poorly to conventional systemic therapies. The first-in-class proteasome inhibitor bortezomib has been approved in clinical use for hematologic malignancies and has shown modest activity in solid tumors, including HCC. However, a considerable proportion of pat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vandewynckel, Yves-Paul, Coucke, Céline, Laukens, Debby, Devisscher, Lindsey, Paridaens, Annelies, Bogaerts, Eliene, Vandierendonck, Astrid, Raevens, Sarah, Verhelst, Xavier, Van Steenkiste, Christophe, Libbrecht, Louis, Geerts, Anja, Van Vlierberghe, Hans
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5085204/ https://www.ncbi.nlm.nih.gov/pubmed/27167000 http://dx.doi.org/10.18632/oncotarget.9222

Ejemplares similares

Placental growth factor inhibition modulates the interplay between hypoxia and unfolded protein response in hepatocellular carcinoma
por: Vandewynckel, Yves-Paul, et al.
Publicado: (2016)

Modulation of the unfolded protein response impedes tumor cell adaptation to proteotoxic stress: a PERK for hepatocellular carcinoma therapy
por: Vandewynckel, Yves-Paul, et al.
Publicado: (2014)

Modulation of the Unfolded Protein Response by Tauroursodeoxycholic Acid Counteracts Apoptotic Cell Death and Fibrosis in a Mouse Model for Secondary Biliary Liver Fibrosis
por: Paridaens, Annelies, et al.
Publicado: (2017)

Tauroursodeoxycholic acid dampens oncogenic apoptosis induced by endoplasmic reticulum stress during hepatocarcinogen exposure
por: Vandewynckel, Yves-Paul, et al.
Publicado: (2015)

Time-Dependent Effect of Hypoxia on Tumor Progression and Liver Progenitor Cell Markers in Primary Liver Tumors
por: Bogaerts, Eliene, et al.
Publicado: (2015)

Effect of prolyl hydroxylase domain 2 haplodeficiency on liver progenitor cell characteristics in early mouse hepatocarcinogenesis
por: Bogaerts, Eliene, et al.
Publicado: (2016)

NOX1 inhibition attenuates the development of a pro‐tumorigenic environment in experimental hepatocellular carcinoma
por: Vandierendonck, Astrid, et al.
Publicado: (2021)

Cerebellar stroke in a low cardiovascular risk patient associated with sorafenib treatment for fibrolamellar hepatocellular carcinoma
por: Vandewynckel, Yves-Paul, et al.
Publicado: (2014)

Characterization of the inflammatory microenvironment and hepatic macrophage subsets in experimental hepatocellular carcinoma models
por: Degroote, Helena, et al.
Publicado: (2021)

Validation of the 2(nd) Generation Proteasome Inhibitor Oprozomib for Local Therapy of Pulmonary Fibrosis
por: Semren, Nora, et al.
Publicado: (2015)

The roles of transforming growth factor-β, Wnt, Notch and hypoxia on liver progenitor cells in primary liver tumours
por: BOGAERTS, ELIENE, et al.
Publicado: (2014)

The neurogliovascular unit in hepatic encephalopathy
por: Claeys, Wouter, et al.
Publicado: (2021)

Prolonged unfolded protein reaction is involved in the induction of chronic myeloid leukemia cell death upon oprozomib treatment
por: Wang, Fang, et al.
Publicado: (2020)

Oprozomib in patients with newly diagnosed multiple myeloma
por: Hari, Parameswaran, et al.
Publicado: (2019)

Effect of isoform-specific HIF-1α and HIF-2α antisense oligonucleotides on tumorigenesis, inflammation and fibrosis in a hepatocellular carcinoma mouse model
por: Vanderborght, Bart, et al.
Publicado: (2020)

Preclinical and Clinical Therapeutic Strategies Affecting Tumor-Associated Macrophages in Hepatocellular Carcinoma
por: Degroote, H., et al.
Publicado: (2018)

A Reliable and Effective UPLC-MS/MS Method for the Determination of Oprozomib in Rat Plasma
por: Li, Xia, et al.
Publicado: (2023)

Oral Proteasomal Inhibitors Ixazomib, Oprozomib, and Delanzomib Upregulate the Function of Organic Anion Transporter 3 (OAT3): Implications in OAT3-Mediated Drug-Drug Interactions
por: Fan, Yunzhou, et al.
Publicado: (2021)

Different Models to Predict the Risk of Recurrent Hepatocellular Carcinoma in the Setting of Liver Transplantation
por: Degroote, Helena, et al.
Publicado: (2022)

Kinetics of angiogenic changes in a new mouse model for hepatocellular carcinoma
por: Heindryckx, Femke, et al.
Publicado: (2010)

Severe Hepatic and Pulmonary Involvement in Rendu-Osler-Weber Syndrome
por: Verhelst, Xavier, et al.
Publicado: (2018)

Health status of patients with autoimmune hepatitis is not affected by the SARS-CoV-2 outbreak in Flanders, Belgium
por: Verhelst, Xavier, et al.
Publicado: (2021)

Rare case of ascites several years after liver transplantation
por: Deroo, Liesbeth, et al.
Publicado: (2022)

Secondary Adrenal Insufficiency after Treatment with Budesonide for Autoimmune Hepatitis
por: De Maeyer, Filip, et al.
Publicado: (2018)

The Angiopoietin/Tie2 Pathway in Hepatocellular Carcinoma
por: Vanderborght, Bart, et al.
Publicado: (2020)

The Gut–Liver Axis in Chronic Liver Disease: A Macrophage Perspective
por: De Muynck, Kevin, et al.
Publicado: (2021)

The epigenetically regulated miR-494 associates with stem-cell phenotype and induces sorafenib resistance in hepatocellular carcinoma
por: Pollutri, Daniela, et al.
Publicado: (2018)

Ubiquitin receptors are required for substrate-mediated activation of the proteasome’s unfolding ability
por: Cundiff, Mary D., et al.
Publicado: (2019)

Combined Therapy with a CCR2/CCR5 Antagonist and FGF21 Analogue Synergizes in Ameliorating Steatohepatitis and Fibrosis
por: Puengel, Tobias, et al.
Publicado: (2022)

Heads or Tails: Genotyping of Hepatitis C Virus Concerning the 2k/1b Circulating Recombinant Form
por: Schuermans, Wim, et al.
Publicado: (2016)

Focal eosinophilic infiltration of the liver, benign or malignant?
por: Claeys, Wouter, et al.
Publicado: (2021)

HDAC and Proteasome Inhibitors Synergize to Activate Pro-Apoptotic Factors in Synovial Sarcoma
por: Laporte, Aimée N., et al.
Publicado: (2017)

A mouse model of hepatic encephalopathy: bile duct ligation induces brain ammonia overload, glial cell activation and neuroinflammation
por: Claeys, Wouter, et al.
Publicado: (2022)

The Proteasomal ATPases Use a Slow but Highly Processive Strategy to Unfold Proteins
por: Snoberger, Aaron, et al.
Publicado: (2017)

poly(I:C) synergizes with proteasome inhibitors to induce apoptosis in cervical cancer cells
por: Meng, Xueqiong, et al.
Publicado: (2022)

Predicting the response of multiple myeloma to the proteasome inhibitor Bortezomib by evaluation of the unfolded protein response
por: Nikesitch, N, et al.
Publicado: (2016)

Contribution of the Unfolded Protein Response (UPR) to the Pathogenesis of Proteasome-Associated Autoinflammatory Syndromes (PRAAS)
por: Ebstein, Frédéric, et al.
Publicado: (2019)

Lipoic Acid Synergizes with Antineoplastic Drugs in Colorectal Cancer by Targeting p53 for Proteasomal Degradation
por: Neitzel, Carina, et al.
Publicado: (2019)

Assessment of faecal microbial transfer in irritable bowel syndrome with severe bloating
por: Holvoet, Tom, et al.
Publicado: (2017)

XPO1 inhibition with selinexor synergizes with proteasome inhibition in neuroblastoma by targeting nuclear export of IkB
por: Galinski, Basia, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_iq75l956267sr8a71rbaan84vo